Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, United Kingdom.
JAMA Netw Open. 2023 Feb 1;6(2):e230133. doi: 10.1001/jamanetworkopen.2023.0133.
IMPORTANCE: Maternal infection is common during pregnancy and is an important potential cause of fetal genetic and immunological abnormalities. Maternal infection has been reported to be associated with childhood leukemia in previous case-control or small cohort studies. OBJECTIVE: To evaluate the association of maternal infection during pregnancy with childhood leukemia among offspring in a large study. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study used data from 7 Danish national registries (including the Danish Medical Birth Register, the Danish National Patient Registry, the Danish National Cancer Registry, and others) for all live births in Denmark between 1978 and 2015. Swedish registry data for all live births between 1988 and 2014 were used to validate the findings for the Danish cohort. Data were analyzed from December 2019 to December 2021. EXPOSURES: Maternal infection during pregnancy categorized by anatomic locations identified from the Danish National Patient Registry. MAIN OUTCOMES AND MEASURES: The primary outcome was any leukemia; secondary outcomes were acute lymphoid leukemia (ALL) and acute myeloid leukemia (AML). Offspring childhood leukemia was identified in the Danish National Cancer Registry. Associations were first assessed in the whole cohort using Cox proportional hazards regression models, adjusted for potential confounders. A sibling analysis was performed to account for unmeasured familial confounding. RESULTS: This study included 2 222 797 children, 51.3% of whom were boys. During the approximately 27 million person-years of follow-up (mean [SD], 12.0 [4.6] years per person), 1307 children were diagnosed with leukemia (ALL, 1050; AML, 165; or other, 92). Children born to mothers with infection during pregnancy had a 35% increased risk of leukemia (adjusted hazard ratio [HR], 1.35 [95% CI, 1.04-1.77]) compared with offspring of mothers without infection. Maternal genital and urinary tract infections were associated with a 142% and 65% increased risk of childhood leukemia, with HRs of 2.42 (95% CI, 1.50-3.92) and 1.65 (95% CI, 1.15-2.36), respectively. No association was observed for respiratory tract, digestive, or other infections. The sibling analysis showed comparable estimates to the whole-cohort analysis. The association patterns for ALL and AML were similar to that for any leukemia. No association was observed for maternal infection and brain tumors, lymphoma, or other childhood cancers. CONCLUSIONS AND RELEVANCE: In this cohort study of approximately 2.2 million children, maternal genitourinary tract infection during pregnancy was associated with childhood leukemia among offspring. If confirmed in future studies, our findings may have implications for understanding the etiology and developing preventive measures for childhood leukemia.
重要性:孕妇感染很常见,是导致胎儿遗传和免疫异常的重要潜在原因。在以前的病例对照或小队列研究中,已经有报道称母体感染与儿童白血病有关。 目的:在一项大型研究中评估孕妇感染与后代儿童白血病之间的关联。 设计、地点和参与者:这项基于人群的队列研究使用了来自 7 个丹麦国家登记处(包括丹麦医学出生登记处、丹麦国家患者登记处、丹麦国家癌症登记处等)的数据,涵盖了 1978 年至 2015 年期间丹麦所有的活产儿。使用瑞典登记处 1988 年至 2014 年期间所有活产儿的数据对丹麦队列进行了验证。数据于 2019 年 12 月至 2021 年 12 月进行分析。 暴露:妊娠期间的母体感染,通过丹麦国家患者登记处确定的解剖部位进行分类。 主要结局和测量指标:主要结局为任何白血病;次要结局为急性淋巴细胞白血病(ALL)和急性髓细胞白血病(AML)。在丹麦国家癌症登记处发现儿童期白血病。在整个队列中,首先使用 Cox 比例风险回归模型评估了关联,调整了潜在的混杂因素。进行了同胞分析以考虑未测量的家族混杂因素。 结果:本研究共纳入 2222797 名儿童,其中 51.3%为男孩。在大约 2700 万人年的随访期间(平均[SD],每人 12.0[4.6]年),有 1307 名儿童被诊断患有白血病(ALL 为 1050 例,AML 为 165 例,其他为 92 例)。与母亲未感染的子女相比,母亲在妊娠期间感染的子女患白血病的风险增加了 35%(调整后的危险比[HR],1.35[95%CI,1.04-1.77])。母亲的生殖道和泌尿道感染与儿童白血病的风险分别增加了 142%和 65%,HR 分别为 2.42(95%CI,1.50-3.92)和 1.65(95%CI,1.15-2.36)。呼吸道、消化道或其他感染与儿童白血病无关。同胞分析显示与全队列分析结果相似。ALL 和 AML 的关联模式与任何白血病相似。母亲感染与脑肿瘤、淋巴瘤或其他儿童癌症无关。 结论和相关性:在这项约 220 万儿童的队列研究中,母亲在妊娠期间的生殖道感染与后代儿童白血病有关。如果在未来的研究中得到证实,我们的发现可能对理解儿童白血病的病因和制定预防措施具有重要意义。
J Natl Cancer Inst. 1997-7-2
Cancers (Basel). 2025-2-21
Cancers (Basel). 2025-1-23
Clin Transl Immunology. 2024-3-23
Cancer Epidemiol Biomarkers Prev. 2021-8
Nat Rev Cancer. 2018-8
Eur J Epidemiol. 2018-1-19
Acta Oncol. 2017-12-11
Semin Immunopathol. 2017-10-2
Lancet Oncol. 2017-4-11